Exicure, Inc. Common Stock

XCURNASDAQ • USD
ThemeGenomics & Precision Med.›RNA Therapeutics
2.92 USD
↘ 0.04 (1.35%)AT CLOSE (11:59 AM EDT)
2.92
↘ 0.01 (0.17%)
POST MARKET (AS OF 06:37 PM EDT)
Post Market
AS OF 06:37 PM EDT
2.92
↘ 0.01 (0.17%)
🔴Market: CLOSED
Open?$3.00
High?$3.09
Low?$2.79
Prev. Close?$2.96
Volume?17.3K
Avg. Volume?14.5K
VWAP?$2.97
Rel. Volume?1.20x
Bid / Ask
Bid?$2.97 × 100
Ask?$3.09 × 300
Spread?$0.12
Midpoint?$3.03
Valuation & Ratios
Market Cap?18.6M
Shares Out?6.4M
Float?4.3M
Float %?67.2%
P/E Ratio?N/A
P/B Ratio?8.87
EPS?-$1.54
Dividend?0.00%
Ex-Dividend?N/A

Exicure, Inc. Common Stock (XCUR) is currently trading at $2.92. Technical and fundamental signals converge bearish — technicals rate "Strong Sell" while fundamentals read "Sell". This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation front, XCUR trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.

Technical & fundamental data as of Jun 5, 2026.

News
Profile
Exicure Inc is a clinical-stage biotechnology company focused on developing treatments for blood-related diseases, with an emphasis on small-molecule therapies that have the potential to benefit a broad range of patients. The company acquired GPCR Therapeutics USA and secured a license for GPC-100 (Burixafor), a clinical-stage small-molecule compound that inhibits the chemokine receptor CXCR4. GPC-100 has demonstrated the ability to effectively mobilize various cell types, including hematopoietic stem cells and lymphocytes, highlighting its broad therapeutic potential across multiple indications.
Themes
Healthcare - Genomics & Precision Medicine›RNA TherapeuticsBiotech - Drug Development›Rare Disease Therapeutics
Employees
8
Market Cap
18.9M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.exicuretx.com
Listed
2018-05-09
Address
2430 N. HALSTED ST.
CHICAGO, IL 60614
Phone: 847-673-1707
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
50
Short Sent.?
94
Piotroski F-Score?0/9Weak
Altman Z-Score?-22.36Distress
Confidence?40%Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?0.75%Low
Short Interest?32.3K
Days to Cover?2.4
Free Float4.3M
Avg Daily Volume13.6K
Settlement Date2026-05-15
Financial Health
Current Ratio?0.79Weak
Quick Ratio?0.79Weak
Cash Ratio?0.58Adequate
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
Peers
100
S&P
21
8.87HIGH▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-1.9CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
3
-466.4%WEAK▾
ROA?
S&P
3
-76.7%WEAK▾
Cash Flow & Enterprise
FCF?$-8100000
Enterprise Value?$16.0M
Fundamentals ratios updated end of day
MarketsMoversWatchlist